iLoF frequently appears in and contributes to leading publications and media outlets. Continue on to Read/Watch/Listen and learn more about iLof—what we do, what we think and how we are changing the future.
iLoF receive $1m from Microsoft & Mayfield Fund
ILoF (Intelligent Lab on Fiber) has today [15 July] received $1 million from Microsoft’s venture fund M12, Mayfield, and Melinda Gates’s Pivotal Ventures.
ILoF are one of four teams chosen from female-led companies from around the world to receive a share of $6m investment, resources and mentoring through the Female Founders Program.
iLoF Co-founder and CTO, Joana Paiva speaks at i2AI on 17 July 2020
Paiva’s session will focus on some of the pains behind drug development for heterogeneous diseases, and how they can be tackled using a #cloudbased library of disease #biomarkers and biological profiles.
iLoF featured at Google for Startups Showcase on 15 July 2020 at 14:00
iLoF will be one of ten startups to appear.
A disease-biomarker-library startup a day keeps the FOMO away. (Daily Dealflow)
iLoF featured in The Daily Dealflow which delivers one vetted startup to your inbox every workday.
iLoF: usar a inteligência artificial para ter uma biblioteca de biomarcadores — e detectar células cancerosas (Publico.pt)
iLoF advances to other areas beyond Alzheimers and distinguishes and detects cancer cells, which is central to determining the optimal treatment.
Tech Talks Podcast
iLoF CEO Luis Valente talks to Tech Talk about the difficulty in finding a cure for Alzheimer’s, and why with an aging population it is key to try and find treatments and cures for individuals with increasingly complex medical profiles.
Entrepreneur XXI Awards
iLoF chosen by Fundacion “la Caixa”and Banco BPI as a finalist for the Entrepreneur XXI Awards.
iLoF assisting physicians in the fight against COVID-19
iLoF enables the stratification of tens of thousands of patients daily.
Investigação científica: iLoF: usar a inteligência artificial para ter uma biblioteca de biomarcadores — e detectar células cancerosas (Publico.pt)
iLoF discusses how they want to accelerate personalized medicine.
Investigadores estudam forma personalizada de prever evolução da infeção (Observador)
Ferramenta é “baseada em medicina personalizada, rápida e de baixo custo” e poderá ser utilizada para prever a evolução da infeção por Covid-19 nos pacientes, segundo a Faculdade de Medicina do Porto.
Google for Startups UK
iLoF joins the new Google for Startups UK program.
iLoF participates in the Mayor of London’s Techinvest.
M12 Venture Fund Microsoft Female Founders Competition
iLoF named a finalist in Microsoft’s Female Founders Competition.
Equipa do Porto desenvolvem sistema que deteta células cancerígenas
iLoF study demonstrates how their smart device can aid in the identification of cancer cells.
Forbes 30 Under 30
iLoF Co-founders are named in Forbes 30 Under 30 for Science & Healthcare.
Hello Tomorrow Global Summit
iLoF named a Deep Tech Pioneer.
50 Gamechangers in the Thames Valley
iLoF named one of 50 Gamechangers around Oxford and Thames Valley.
iLoF Co-founder and CTO Joana Paiva speaks about enabling a new generation of personalized treatments.
Startup World Cup London
iLoF selected as one of the 10 most incredible startups and given the opportunity to present their vision at London’s Biohacking Congress.
iLoF Co-founder and COO Mehak Mumtaz appeared before Rising WISE discussing our EIT Health Wildcard Journey.
Using Optical Fibers to Change the World (Jornal de Noticias)
Co-founder and CTO Joana Paiva discusses how we are using optical fibers and artificial intelligence to enable personalized treatments.
iLoF Joins Oxford Foundry (Medium)
iLoF is selected to participate in the Lev8 program at Oxford Foundry, Oxford University’s startup incubator.
iLoF wins EIT Jumpstarter and Digital Freedom Fest
In Riga, iLoF awarded 10,000 euros at EIT’s Jumpstarter 2019 for winning the Health category. At the same time, it was selected by Rockstart as a “Future Unicorn” at the Digital Freedom Fest.
Startup recebe 2ME para combater doença de Alzheimer (Antena Livre)
Uma ‘startup’ do Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência (INESC TEC) recebeu dois milhões de euros de um programa de aceleração para, através da inteligência artificial e da fotónica, combater o Alzheimer.
Altice Innovation Award media coverage
Criar uma maior proximidade entre a academia, as startup e o tecido empresarial é o objectivo do prémio Altice International Innovation Award, que vai na 3ª edição.
ILoF named a finalist of the Altice International Innovation Award
Watch iLoF CEO Luis outline what sparked the creation of iLoF.
Andámos à caça de geeks na Web Summit. Apanhámos estas cinco ideias portuguesas (Observador.pt)
Madalena, João, Lourenço, Rui, David e Luís. Este foram os geeks caçados pelo Observador na quarta edição da Web Summit. Todos têm um pitch cativante e todos prometem revolucionar vários mercados.
2019 European Angel Investment Summit hosted by European Business Angels Network (EBAN)
iLoF presents our solution to a high-level audience of officials, investors, and industry experts.
Digital Freedom Festival
iLoF wins Future Unicorn Pitch Competition.
Startup portuguesa recebe dois milhões de euros para combater Alzheimer (Público Online)
Uma startup do Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência (INESC TEC) recebeu dois milhões de euros de um programa de aceleração para, através da inteligência artificial e da fotónica, combater o Alzheimer, foi anunciado esta quarta-feira, 6 de Novembro.
Startup nascida no Porto recebe 2 milhões de euros para combater a doença do Alzheimer (Observador Online)
Através da inteligência artificial e da fotónica, o “sistema portátil” serve de arquivo a “impressões digitais” e permite “testes rápidos e pouco invasivos.
Wild Card 2019 is investing up to 4 million euros in new ventures, Pipra and iLoF
iLoF wins the Wild Card accelerator program and received 2 million euros of investment from EIT Health
(+351) 220 426 664 / (+44) 01865 679064
Oxford Foundry – University of Oxford
3-5 Hythe Bridge St
Oxford – United Kingdom
Medical Research Center - Faculty of Medicine of University of Porto - Alameda Prof. Hernâni Monteiro Porto - Portugal